Total Payments
$2,523
2024 Payments
$842.51
Companies
29
Transactions
123
Medicare Patients
4,022
Medicare Billing
$565,154
Payment Breakdown by Category
Food & Beverage$2,523 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,523 | 123 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $348.44 | 19 | $0 (2024) |
| Novo Nordisk Inc | $301.45 | 16 | $0 (2024) |
| PFIZER INC. | $222.67 | 11 | $0 (2024) |
| Abbott Laboratories | $191.43 | 9 | $0 (2024) |
| NeuroMetrix Inc | $164.96 | 1 | $0 (2023) |
| Amgen Inc. | $159.50 | 9 | $0 (2024) |
| ABBVIE INC. | $149.40 | 7 | $0 (2024) |
| Madrigal Pharmaceuticals | $119.03 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $95.84 | 6 | $0 (2024) |
| GlaxoSmithKline, LLC. | $95.31 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $842.51 | 40 | Novartis Pharmaceuticals Corporation ($214.72) |
| 2023 | $1,015 | 45 | NeuroMetrix Inc ($164.96) |
| 2022 | $479.14 | 26 | Novartis Pharmaceuticals Corporation ($94.73) |
| 2020 | $43.26 | 3 | Novo Nordisk Inc ($25.02) |
| 2019 | $110.15 | 7 | Novo Nordisk Inc ($37.23) |
| 2018 | $33.02 | 2 | Novo Nordisk Inc ($18.18) |
All Payment Transactions
123 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: VACCINE | ||||||
| 12/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Inflammation | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $10.42 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: VACCINES | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $9.03 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Inflammation | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/03/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $119.03 | General |
| Category: LIVER DISEASE | ||||||
| 10/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Diabetes Care | ||||||
| 09/18/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 08/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: RESPIRATORY | ||||||
| 07/17/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Inflammation | ||||||
| 06/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: PAIN | ||||||
| 05/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/21/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $0.85 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: RESPIRATORY | ||||||
| 05/08/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.05 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 839 | 1,275 | $376,625 | $120,776 |
| 2022 | 13 | 953 | 1,342 | $396,464 | $122,201 |
| 2021 | 14 | 954 | 1,353 | $462,059 | $148,401 |
| 2020 | 19 | 1,276 | 2,001 | $608,837 | $173,777 |
Total Patients
4,022
Total Services
5,971
Medicare Billing
$565,154
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 268 | 584 | $173,448 | $51,977 | 30.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 127 | 215 | $85,785 | $28,105 | 32.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 197 | 197 | $60,873 | $26,191 | 43.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 21 | 21 | $12,075 | $3,136 | 26.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 12 | $7,644 | $2,727 | 35.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 11 | 11 | $5,126 | $1,878 | 36.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 12 | 16 | $7,216 | $1,558 | 21.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $6,915 | $1,134 | 16.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 20 | $4,040 | $949.96 | 23.5% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 46 | 46 | $2,392 | $866.64 | 36.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 16 | 18 | $3,780 | $726.58 | 19.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 37 | 37 | $1,924 | $697.08 | 36.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 24 | 40 | $2,600 | $404.60 | 15.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 23 | 30 | $2,430 | $313.56 | 12.9% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 11 | 13 | $377.00 | $111.18 | 29.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 302 | 573 | $170,181 | $49,242 | 28.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 136 | 224 | $89,376 | $31,101 | 34.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 126 | 126 | $38,934 | $16,766 | 43.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 44 | 44 | $20,504 | $7,617 | 37.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 31 | 31 | $17,825 | $4,462 | 25.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 53 | 53 | $24,433 | $4,446 | 18.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 52 | 56 | $11,312 | $3,197 | 28.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 12 | 15 | $6,765 | $1,254 | 18.5% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 64 | 64 | $3,328 | $1,222 | 36.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 21 | 25 | $5,250 | $1,088 | 20.7% |
About Dr. Manuel Jimenez Rodriguez, MD
Dr. Manuel Jimenez Rodriguez, MD is a Internal Medicine healthcare provider based in Naples, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2009. The National Provider Identifier (NPI) number assigned to this provider is 1154550762.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Manuel Jimenez Rodriguez, MD has received a total of $2,523 in payments from pharmaceutical and medical device companies, with $842.51 received in 2024. These payments were reported across 123 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($2,523).
As a Medicare-enrolled provider, Jimenez Rodriguez has provided services to 4,022 Medicare beneficiaries, totaling 5,971 services with total Medicare billing of $565,154. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Naples, FL
- Active Since 07/06/2009
- Last Updated 12/17/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1154550762
Products in Payments
- LEQVIO (Drug) $225.68
- Ozempic (Drug) $156.23
- Otezla (Drug) $129.43
- FREESTYLE LIBRE 2 (Device) $126.87
- ENTRESTO (Drug) $122.76
- RESMETIROM (Drug) $119.03
- ELIQUIS (Drug) $118.94
- TRELEGY ELLIPTA (Drug) $95.31
- VRAYLAR (Drug) $81.17
- Cologuard Collection Kit (Device) $77.86
- Tresiba (Drug) $71.08
- NURTEC ODT (Drug) $66.86
- FARXIGA (Drug) $58.23
- EMGALITY (Drug) $57.29
- REXULTI (Drug) $56.79
- Rybelsus (Drug) $54.00
- XARELTO (Drug) $51.40
- FREESTYLE LIBRE 3 (Device) $41.02
- QUVIVIQ (Drug) $37.63
- GARDASIL 9 (Biological) $34.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Naples
Edward Salerno, Md, MD
Internal Medicine — Payments: $176,717
Internal Medicine $176,717
Valeriu Neagu, M.d, M.D
Internal Medicine — Payments: $140,761
Internal Medicine $140,761
Reynald Allam, Md, MD
Internal Medicine — Payments: $93,172
Internal Medicine $93,172
Mazen Albaghdadi, M.d, M.D
Internal Medicine — Payments: $30,780
Internal Medicine $30,780
Luis Pozniak, Md, MD
Internal Medicine — Payments: $29,652
Internal Medicine $29,652
Dr. Gustavo Rivera, Md, MD
Internal Medicine — Payments: $22,056
Internal Medicine $22,056